FDA Committee Supports Janssen COVID-19 Vaccine Booster
The panel reviewed safety and efficacy data from the phase 3 ENSEMBLE 2 study.
COVID19
REGEN-COV Gets Priority Review for COVID-19 Treatment, Prophylaxis
The BLA submission is supported by data from two phase 3 trials that included more than 6000 patients.
An Evaluation of Direct-to-Consumer Pulse Oximetry Devices
How reliable are the 10 most popular consumer pulse oximeters used for home monitoring?
The Ongoing Challenge of Attracting and Retaining Health Care Providers
The pandemic has accelerated the number of clinicians retiring from practice.
Emergency Use Request Submitted for Molnupiravir for Mild to Moderate COVID-19
The submission is based on data from the phase 3 MOVe-OUT trial, which evaluated molnupiravir in 775 nonhospitalized adults with mild to moderate COVID-19.
Ciclesonide May Be Promising Outpatient Therapy for Early COVID-19
Clinical trial results indicate that ciclesonide inhalation may be an effective early antiviral therapy for mild to moderate COVID-19.
Pfizer-BioNTech Submit Request for Emergency Use of Pediatric COVID-19 Vaccine
The Companies recently submitted data from a phase 2/3 trial that included 2268 pediatric participants.
COVID-19 Pandemic Has Altered the Perception of Mask-Wearing Faces
Investigators assessed the impact of mask wearing on perception of health during the COVID-19 pandemic.
Pandemic Measures Reduced Diabetic Eye Disease Monitoring, Treatments
Patients with diabetes underwent fewer injections and experienced worse vision loss than others, a report shows.
Oral Antiviral Molnupiravir Cuts Risk of COVID-19 Hospitalization, Death
The planned interim analysis included data from 775 adult patients with mild to moderate COVID-19.
- Loading...
Loading...
Loading... 
Loading...